User profiles for "author:Alex Semprini"
Alex SempriniDeputy Director, Medical Research Institute of New Zealand Verified email at mrinz.ac.nz Cited by 1594 |
Risk factors for asthma: is prevention possible?
R Beasley, A Semprini, EA Mitchell - The Lancet, 2015 - thelancet.com
Asthma is one of the most common diseases in the world, resulting in a substantial burden of
disease. Although rates of deaths due to asthma worldwide have reduced greatly over the …
disease. Although rates of deaths due to asthma worldwide have reduced greatly over the …
Optimal asthma control: time for a new target
R Beasley, I Braithwaite, A Semprini… - American Journal of …, 2020 - atsjournals.org
The stepwise approach to pharmacological treatment in adult asthma mandates that asthma
treatment is progressively stepped up to achieve symptom control and reduce the risk of …
treatment is progressively stepped up to achieve symptom control and reduce the risk of …
Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group …
Background Whether blood eosinophil counts and exhaled nitric oxide (FeNO) are
associated with important outcomes in mild asthma is unclear. In this prespecified subgroup …
associated with important outcomes in mild asthma is unclear. In this prespecified subgroup …
Cannabis in palliative care: a systematic review of current evidence
M Doppen, S Kung, I Maijers, M John, H Dunphy… - Journal of Pain and …, 2022 - Elsevier
Context Palliative care aims to improve the quality of life in patients with incurable illness.
Medicinal cannabis (MC) has been used in the palliative care setting to address multiple …
Medicinal cannabis (MC) has been used in the palliative care setting to address multiple …
[HTML][HTML] An Aotearoa New Zealand survey of the impact and diagnostic delay for endometriosis and chronic pelvic pain
J Tewhaiti-Smith, A Semprini, D Bush, A Anderson… - Scientific reports, 2022 - nature.com
Chronic pelvic pain (CPP) causes important negative effects on quality of life. Endometriosis
is the most common cause of CPP in females, and diagnostic delay is over six years …
is the most common cause of CPP in females, and diagnostic delay is over six years …
[HTML][HTML] Kanuka honey versus aciclovir for the topical treatment of herpes simplex labialis: a randomised controlled trial
A Semprini, J Singer, I Braithwaite, N Shortt… - BMJ open, 2019 - bmjopen.bmj.com
Objective To compare New Zealand medical grade kanuka honey with topical aciclovir for
the treatment of herpes simplex labialis. Design Prospective parallel randomised controlled …
the treatment of herpes simplex labialis. Design Prospective parallel randomised controlled …
How big is your bubble? Characteristics of self-isolating household units ('bubbles') during the COVID-19 Alert Level 4 period in New Zealand: A cross-sectional …
N Kearns, N Shortt, C Kearns, A Eathorne, M Holliday… - BMJ open, 2021 - bmjopen.bmj.com
Objective To characterise the self-isolating household units (bubbles) during the COVID-19
Alert Level 4 lockdown in New Zealand. Design, setting and participants In this cross …
Alert Level 4 lockdown in New Zealand. Design, setting and participants In this cross …
ICS-formoterol reliever therapy stepwise treatment algorithm for adult asthma
R Beasley, I Braithwaite, A Semprini… - European …, 2020 - Eur Respiratory Soc
A stepwise approach to the pharmacological treatment of asthma is a key feature of current
asthma guidelines [1–4]. Through algorithms, treatment intensity is “stepped up” to obtain …
asthma guidelines [1–4]. Through algorithms, treatment intensity is “stepped up” to obtain …
[HTML][HTML] The Anti-Inflammatory Reliever (AIR) Algorithm Study: a protocol for a single-group study of an AIR stepwise approach to the treatment of adult asthma
Background The stepwise approach to long-term asthma management, which traditionally
incorporates short-acting β2-agonist reliever therapy, has been a core feature of asthma …
incorporates short-acting β2-agonist reliever therapy, has been a core feature of asthma …
Type 2 biomarkers and prediction of future exacerbations and lung function decline in adult asthma
R Semprini, M Williams, A Semprini, A McDouall… - The Journal of Allergy …, 2018 - Elsevier
Background Type 2 biomarkers that predict both likelihood of future severe exacerbations
and response to mAb therapy in asthma would be useful clinically in identifying patients both …
and response to mAb therapy in asthma would be useful clinically in identifying patients both …